QVT FINANCIAL
QVT Financial LP is a privately owned hedge fund sponsor. The firm provides its services to pooled investment vehicles. It invests in public equity and debt across the globe. The firm also invests in alternative investment markets across the globe. It invests in structured finance, private placements, high yield, and distressed debt to create its portfolios. The firm employs convertible arbitrage, investment grade, and capital structure arbitrage techniques along with closed-end fund arbitrage and various relative value-driven equity strategies such as risk arbitrage, fundamental relative value, statistical trades, and other special situation techniques to its investments. QVT Financial is based in New York, New York with an additional office in London, United Kingdom.
QVT FINANCIAL
Social Links:
Industry:
Hedge Funds
Founded:
2003-01-01
Status:
Active
Contact:
+1 212 705 8888
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Google Universal Analytics Font Awesome
Current Employees Featured
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-05-16 | Kriya Therapeutics | QVT Financial investment in Series C - Kriya Therapeutics | 270 M USD |
2021-07-14 | Kriya Therapeutics | QVT Financial investment in Series B - Kriya Therapeutics | 100 M USD |
2020-05-12 | Kriya Therapeutics | QVT Financial investment in Series A - Kriya Therapeutics | 80.5 M USD |
2018-11-13 | Roivant Sciences | QVT Financial investment in Private Equity Round - Roivant Sciences | 200 M USD |
2015-09-21 | Akari Therapeutics | QVT Financial investment in Post-IPO Equity - Akari Therapeutics | 75 M USD |
2015-09-08 | AveXis | QVT Financial investment in Series D - AveXis | 65 M USD |
2015-05-20 | REGENXBIO | QVT Financial investment in Series D - REGENXBIO | 70.5 M USD |
2014-12-24 | Palatin Technologies | QVT Financial investment in Post-IPO Equity - Palatin Technologies | 20 M USD |
2014-09-25 | Adaptimmune | QVT Financial investment in Series A - Adaptimmune | 104 M USD |
2014-09-08 | Flex Pharma | QVT Financial investment in Venture Round - Flex Pharma | 40 M USD |